The potent sphingosine-1-phosphate receptor antagonist fingolimod (FTY720) significantly attenuates MPTP-induced PD progression and reduces the loss of DA neurons by inhibiting NLRP3 inflammasome activation (Yao et al., 2019). Here, NLRP3 is linked to Parkinson disease.